IE912025A1 - Substituted benzimidazoles, process for their preparation¹and their pharmaceutical use - Google Patents

Substituted benzimidazoles, process for their preparation¹and their pharmaceutical use

Info

Publication number
IE912025A1
IE912025A1 IE202591A IE202591A IE912025A1 IE 912025 A1 IE912025 A1 IE 912025A1 IE 202591 A IE202591 A IE 202591A IE 202591 A IE202591 A IE 202591A IE 912025 A1 IE912025 A1 IE 912025A1
Authority
IE
Ireland
Prior art keywords
methyl
compound according
compound
benzimidazole
carbon atoms
Prior art date
Application number
IE202591A
Other languages
English (en)
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of IE912025A1 publication Critical patent/IE912025A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
IE202591A 1990-06-20 1991-06-14 Substituted benzimidazoles, process for their preparation¹and their pharmaceutical use IE912025A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9002206A SE9002206D0 (sv) 1990-06-20 1990-06-20 New compounds

Publications (1)

Publication Number Publication Date
IE912025A1 true IE912025A1 (en) 1992-01-01

Family

ID=20379831

Family Applications (1)

Application Number Title Priority Date Filing Date
IE202591A IE912025A1 (en) 1990-06-20 1991-06-14 Substituted benzimidazoles, process for their preparation¹and their pharmaceutical use

Country Status (27)

Country Link
EP (1) EP0535081A1 (fr)
JP (1) JPH05507713A (fr)
CN (1) CN1058212A (fr)
AP (1) AP215A (fr)
AU (1) AU649453B2 (fr)
BG (1) BG97200A (fr)
CA (1) CA2083714A1 (fr)
CZ (1) CZ279772B6 (fr)
FI (1) FI925766A0 (fr)
HU (1) HUT62881A (fr)
IE (1) IE912025A1 (fr)
IL (1) IL98470A0 (fr)
IS (1) IS3721A7 (fr)
LT (2) LT3952B (fr)
LV (1) LV10953A (fr)
MA (1) MA22199A1 (fr)
NO (1) NO924775L (fr)
NZ (1) NZ238546A (fr)
OA (1) OA09682A (fr)
PT (1) PT98035A (fr)
RO (1) RO110493B1 (fr)
SE (1) SE9002206D0 (fr)
TN (1) TNSN91049A1 (fr)
TW (1) TW216418B (fr)
WO (1) WO1991019711A1 (fr)
YU (1) YU104191A (fr)
ZA (2) ZA914297B (fr)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9002043D0 (sv) * 1990-06-07 1990-06-07 Astra Ab Improved method for synthesis
SE9103776D0 (sv) * 1991-12-19 1991-12-19 Astra Ab New compounds
IS4232A (is) * 1993-12-06 1995-06-07 Astra Aktiebolag Súbstitúerað bensimidasól, aðferðir við framleiðslu þess og lyfjafræðileg notkun
SE9500422D0 (sv) * 1995-02-06 1995-02-06 Astra Ab New oral pharmaceutical dosage forms
SE9500478D0 (sv) * 1995-02-09 1995-02-09 Astra Ab New pharmaceutical formulation and process
SE9600070D0 (sv) 1996-01-08 1996-01-08 Astra Ab New oral pharmaceutical dosage forms
PT1257269E (pt) 2000-02-24 2005-03-31 Kopran Res Lab Ltd Derivados do benzimidazole anti-ulcera estavel em relacao ao acido de administracao oral
SE0101379D0 (sv) 2001-04-18 2001-04-18 Diabact Ab Komposition som hämmar utsöndring av magsyra
US8206741B2 (en) 2001-06-01 2012-06-26 Pozen Inc. Pharmaceutical compositions for the coordinated delivery of NSAIDs
US7906145B2 (en) 2002-04-09 2011-03-15 Flamel Technologies Oral pharmaceutical formulation in the form of aqueous suspension for modified release of active principle(s)
SE0203065D0 (sv) 2002-10-16 2002-10-16 Diabact Ab Gastric acid secretion inhibiting composition
JP4919801B2 (ja) 2003-09-26 2012-04-18 アルザ・コーポレーシヨン 高い薬剤配合量を提供する薬剤コーティング及びそれを提供する方法
TW200606163A (en) 2004-04-22 2006-02-16 Eisai Co Ltd Imidazopyridine compound
US8541026B2 (en) 2004-09-24 2013-09-24 Abbvie Inc. Sustained release formulations of opioid and nonopioid analgesics
US20070015782A1 (en) 2005-04-15 2007-01-18 Eisai Co., Ltd. Benzimidazole compound
US9040564B2 (en) 2005-04-28 2015-05-26 Eisai R&D Management Co., Ltd. Stabilized composition
US7803817B2 (en) 2005-05-11 2010-09-28 Vecta, Ltd. Composition and methods for inhibiting gastric acid secretion
US7981908B2 (en) 2005-05-11 2011-07-19 Vecta, Ltd. Compositions and methods for inhibiting gastric acid secretion
WO2007122686A1 (fr) * 2006-04-14 2007-11-01 Eisai R & D Management Co., Ltd. Composes benzimidazole
EP2046334B1 (fr) 2006-07-25 2014-05-21 Vecta Ltd. Compositions et procédés d'inhibition de sécrétion d'acide gastrique utilisant des dérivés de petits acides dicarboxyliques combinés á un ipp
JP5492417B2 (ja) * 2006-10-13 2014-05-14 エーザイ・アール・アンド・ディー・マネジメント株式会社 胃酸分泌抑制作用を有するベンズイミダゾール化合物
CN102209529A (zh) 2008-09-09 2011-10-05 阿斯利康(瑞典)有限公司 将药物组合物递送至有需要的患者的方法
EP2445499A4 (fr) 2009-06-25 2013-02-27 Astrazeneca Ab Procede pour le traitement d'un patient a risque de developer un ulcere associe a nsaid
WO2011080500A2 (fr) 2009-12-29 2011-07-07 Orexo Ab Nouvelle forme pharmaceutique destinée au traitement de troubles liés à l'acide gastrique
WO2011080502A2 (fr) 2009-12-29 2011-07-07 Orexo Ab Nouvelle forme pharmaceutique destinée au traitement de troubles liés à l'acide gastrique
US20120294937A1 (en) 2009-12-29 2012-11-22 Novartis Ag New pharmaceutical dosage form for the treatment of gastric acid-related disorders
EP2601947A1 (fr) 2011-12-05 2013-06-12 Abo Bakr Mohammed Ali Al-Mehdar Combinaison à dose fixe pour le traitement de maladies associées à Hélicobacter pylori
WO2013101897A2 (fr) 2011-12-28 2013-07-04 Pozen Inc. Compositions et procédés d'administration d'oméprazole plus acide acétylsalicylique améliorés
TWI659022B (zh) * 2016-09-14 2019-05-11 國立臺灣大學 作為d-胺基酸氧化酶(daao)抑制劑之新穎經取代苯并咪唑衍生物

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE418966B (sv) 1974-02-18 1981-07-06 Haessle Ab Analogiforfarande for framstellning av foreningar med magsyrasekretionsinhiberande verkan
SE416649B (sv) 1974-05-16 1981-01-26 Haessle Ab Forfarande for framstellning av foreningar som paverkar magsyrasekretionen
IN148930B (fr) 1977-09-19 1981-07-25 Hoffmann La Roche
SE7804231L (sv) 1978-04-14 1979-10-15 Haessle Ab Magsyrasekretionsmedel
US4359465A (en) 1980-07-28 1982-11-16 The Upjohn Company Methods for treating gastrointestinal inflammation
CH644116A5 (de) 1980-08-21 1984-07-13 Hoffmann La Roche Imidazolderivate.
SE8300736D0 (sv) 1983-02-11 1983-02-11 Haessle Ab Novel pharmacologically active compounds
SE8301182D0 (sv) 1983-03-04 1983-03-04 Haessle Ab Novel compounds
IL75400A (en) * 1984-06-16 1988-10-31 Byk Gulden Lomberg Chem Fab Dialkoxypyridine methyl(sulfinyl or sulfonyl)benzimidazoles,processes for the preparation thereof and pharmaceutical compositions containing the same
AU568441B2 (en) * 1984-09-24 1987-12-24 Upjohn Company, The 2-(pyridylalkenesulfinyl) benzimidazole derivatives
IL76839A (en) * 1984-10-31 1988-08-31 Byk Gulden Lomberg Chem Fab Picoline derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
US4738975A (en) 1985-07-02 1988-04-19 Takeda Chemical Industries, Ltd. Pyridine derivatives, and use as anti-ulcer agents
SE8505112D0 (sv) * 1985-10-29 1985-10-29 Haessle Ab Novel pharmacological compounds
NZ222495A (en) 1986-11-21 1991-04-26 Haessle Ab Benzimidazole derivatives and pharmaceutical compositions
DE3722810A1 (de) * 1987-07-10 1989-01-19 Hoechst Ag Substituierte benzimidazole, verfahren zu deren herstellung, diese enthaltende pharmazeutische zubereitungen und deren verwendung
JPH02501930A (ja) * 1987-10-30 1990-06-28 アクチエボラゲツト・ヘツスレ 薬学的化合物のための新規な用途
AU2817989A (en) * 1987-12-11 1989-07-05 Byk Gulden Lomberg Chemische Fabrik Gmbh Novel benzimidazole derivatives
WO1989011479A1 (fr) * 1988-05-25 1989-11-30 Byk Gulden Lomberg Chemische Fabrik Gmbh Nouveaux composes fluores d'alkoxyde

Also Published As

Publication number Publication date
WO1991019711A1 (fr) 1991-12-26
SE9002206D0 (sv) 1990-06-20
HUT62881A (en) 1993-06-28
EP0535081A1 (fr) 1993-04-07
LV10953A (lv) 1995-12-20
IS3721A7 (is) 1991-12-21
YU104191A (sh) 1994-01-20
FI925766A (fi) 1992-12-18
AP9100285A0 (en) 1991-07-31
LT3977B (en) 1996-06-25
CA2083714A1 (fr) 1991-12-21
TW216418B (fr) 1993-11-21
ZA914296B (en) 1992-03-25
HU9204033D0 (en) 1993-03-29
PT98035A (pt) 1992-03-31
CZ279772B6 (cs) 1995-06-14
BG97200A (bg) 1993-12-24
OA09682A (en) 1993-05-15
AU8009791A (en) 1992-01-07
LT3952B (en) 1996-05-27
AP215A (en) 1992-09-02
RO110493B1 (ro) 1996-01-30
NZ238546A (en) 1994-03-25
LTIP1713A (en) 1995-08-25
CS189491A3 (en) 1992-04-15
MA22199A1 (fr) 1992-04-01
LTIP1712A (en) 1995-08-25
TNSN91049A1 (fr) 1992-10-25
FI925766A0 (fi) 1992-12-18
ZA914297B (en) 1992-03-25
AU649453B2 (en) 1994-05-26
CN1058212A (zh) 1992-01-29
NO924775D0 (no) 1992-12-10
NO924775L (no) 1992-12-10
IL98470A0 (en) 1992-07-15
JPH05507713A (ja) 1993-11-04

Similar Documents

Publication Publication Date Title
AP215A (en) Substituted benzimidazoles, process for their preparation and their pharmaceutical use.
EP0593463B1 (fr) Derives de dialcoxy-pyridinyle-benzimidazole, procede de preparation et utilisation pharmaceutique de ces derives
EP0449940B1 (fr) Nouveau compose therapeutiquement actif et son procede de preparation
US4965269A (en) Therapeutically active chloro substituted benzimidazoles
EP0451188B1 (fr) Benzimidazole therapeutiquement actif a substitution et son procede de preparation
EP0449935B1 (fr) Compose a effet inhibiteur d'acide gastrique et son procede de preparation
WO1987005021A1 (fr) Benzimidazoles et utilisation pharmaceutique desdits benzimidazoles
WO1995015962A1 (fr) Benzimidazole subtitue, ses procedes de preparation et son utilisation pharmaceutique
IE904248A1 (en) Therapeutically active fluoro substituted benzimidazoles,¹processes for their preparation as well as their use